TRV Rubber Products PCL
SET:TRV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TRV Rubber Products PCL
SET:TRV
|
TH |
|
N
|
Nexgen Energy Ltd
NYSE:NXE
|
CA |
|
Franklin Financial Services Corp
NASDAQ:FRAF
|
US |
|
I
|
Irwin Naturals Inc
CNSX:IWIN
|
US |
|
Neuland Laboratories Ltd
NSE:NEULANDLAB
|
IN |
|
Sichuan Meifeng Chemical Industry Co Ltd
SZSE:000731
|
CN |
|
T
|
Thai Central Chemical PCL
SET:TCCC
|
TH |
|
NI Holdings Inc
NASDAQ:NODK
|
US |
|
Golden Mile Resources Ltd
ASX:G88
|
AU |
Balance Sheet
Balance Sheet Decomposition
TRV Rubber Products PCL
TRV Rubber Products PCL
Balance Sheet
TRV Rubber Products PCL
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
8
|
4
|
111
|
182
|
115
|
250
|
234
|
|
| Cash Equivalents |
0
|
8
|
4
|
111
|
182
|
115
|
250
|
234
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
|
| Total Receivables |
37
|
41
|
45
|
42
|
29
|
185
|
83
|
114
|
|
| Accounts Receivables |
37
|
41
|
45
|
42
|
29
|
185
|
83
|
50
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
64
|
|
| Inventory |
10
|
12
|
11
|
14
|
13
|
10
|
10
|
9
|
|
| Other Current Assets |
1
|
1
|
0
|
0
|
0
|
17
|
8
|
3
|
|
| Total Current Assets |
48
|
62
|
60
|
168
|
224
|
347
|
351
|
360
|
|
| PP&E Net |
122
|
158
|
153
|
145
|
144
|
134
|
123
|
117
|
|
| Intangible Assets |
3
|
2
|
3
|
3
|
2
|
2
|
2
|
1
|
|
| Long-Term Investments |
49
|
49
|
49
|
49
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
6
|
2
|
3
|
3
|
2
|
3
|
15
|
14
|
|
| Total Assets |
228
N/A
|
273
+19%
|
268
-2%
|
367
+37%
|
373
+2%
|
487
+31%
|
492
+1%
|
491
0%
|
|
| Liabilities | |||||||||
| Accounts Payable |
29
|
32
|
38
|
29
|
18
|
18
|
16
|
13
|
|
| Short-Term Debt |
38
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
18
|
21
|
18
|
9
|
9
|
9
|
1
|
1
|
|
| Other Current Liabilities |
4
|
4
|
5
|
3
|
9
|
2
|
2
|
2
|
|
| Total Current Liabilities |
89
|
58
|
63
|
41
|
36
|
28
|
20
|
17
|
|
| Long-Term Debt |
46
|
8
|
26
|
17
|
11
|
2
|
1
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
5
|
6
|
9
|
10
|
10
|
14
|
13
|
|
| Total Liabilities |
137
N/A
|
71
-48%
|
95
+34%
|
67
-29%
|
58
-14%
|
41
-30%
|
35
-15%
|
33
-6%
|
|
| Equity | |||||||||
| Common Stock |
40
|
78
|
78
|
105
|
105
|
120
|
120
|
120
|
|
| Retained Earnings |
51
|
67
|
38
|
45
|
60
|
71
|
82
|
84
|
|
| Additional Paid In Capital |
0
|
58
|
58
|
150
|
150
|
255
|
255
|
255
|
|
| Total Equity |
91
N/A
|
202
+122%
|
173
-14%
|
300
+73%
|
315
+5%
|
446
+42%
|
457
+2%
|
459
+0%
|
|
| Total Liabilities & Equity |
228
N/A
|
273
+19%
|
268
-2%
|
367
+37%
|
373
+2%
|
487
+31%
|
492
+1%
|
491
0%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
210
|
210
|
210
|
210
|
210
|
240
|
240
|
240
|
|